pharmanewsdaily
1509 posts
Sanofi to acquire US biopharma company Principia Biopharma for $3.7bn
Sanofi acquisition of Principia Biopharma : French pharma giant Sanofi has signed an all-cash deal worth $3.68 billion…
August 17, 2020
Northway Biotechpharma to manufacture Memo’s Covid1-9 drug MTX-COVAB
Memo Therapeutics (MTx), a Swiss biotech company, has entered into a partnership with Northway Biotechpharma, under which the…
August 15, 2020
Northway Biotechpharma to manufacture Memo’s Covid1-9 drug MTX-COVAB
Memo Therapeutics (MTx), a Swiss biotech company, has entered into a partnership with Northway Biotechpharma, under which the latter will manufacture the former’s MTX-COVAB – a COVID-19 antibody candidate in a four-month fast-track process. Northway Biotechpharma is a biopharmaceutical contract development and manufacturing organization (CDMO) based in Lithuania. MTX-COVAB, which is the lead antibody candidate […]
August 15, 2020
AstraZeneca finalizes AZD1222 Covid-19 vaccine candidate deal with EC
AstraZeneca said that it has finalized a deal with the European Commission (EC) for the delivery of up…
August 15, 2020
Thermo Fisher scraps $11.5bn Qiagen deal after failed tender offer
Thermo Fisher Scientific has scrapped its previously planned $11.5 billion acquisition of Qiagen after its offer to buy…
August 14, 2020
Moderna bags $1.5bn contract to supply mRNA-1273 Covid-19 vaccine to US govt
Moderna has bagged a deal worth up to $1.52 billion for the manufacturing and supply of 100 million…
August 12, 2020
Bayer to acquire KaNDy Therapeutics to add menopause drug candidate
Bayer has agreed to acquire KaNDy Therapeutics, a UK clinical-stage biotech company, in a deal worth up to…
August 11, 2020
Ligand Pharmaceuticals to acquire protein therapeutics developer Pfenex
US biopharma company Ligand Pharmaceuticals has signed a deal worth up to $516 million to acquire Pfenex, a…
August 11, 2020
Kazia Therapeutics gets US RPDD for paxalisib in childhood brain cancer
Kazia Therapeutics, an Australian biotech company, has secured the rare pediatric disease designation (RPDD) for paxalisib (formerly GDC-0084)…
August 8, 2020
Olympus Corporation to acquire Arc Medical Design from Norgine
Olympus Corporation, a Japanese optical products company, has agreed to acquire Arc Medical Design, a UK-based subsidiary of…
August 8, 2020